Non Small Cell Lung Cancer — Combination of Cetuximab With Afatinib for Patient With EGFR Mutated Lung Cancer
Citation(s)
Phase II Study Evaluating the Combination of Cetuximab With Afatinib as First-line Treatment for Patients With EGFR Mutated Non Small Cell Lung Cancer